Blood Tests to Track Senolytic Progress: A Biomarker Guide

Expert Summary

The optimal monitoring panel for self-directed senolytic protocols combines general inflammatory markers (hsCRP, IL-6) with a specific SASP marker (GDF15 or MMP-3), metabolic markers that reflect senescent fat cell activity, and functional self-assessment. Total cost from standard commercial labs: $50–150 per panel.

Key Facts

• hsCRP (high-sensitivity CRP): Order from LabCorp, Quest, or through a direct-access lab. Cost: $15–30. Measure before starting senolytics (baseline), 4 weeks after first burst, then every 6 months. Target: <1 mg/L. Trend toward lower values confirms anti-inflammatory effect.
• IL-6: Available through most commercial labs. Cost: $30–60. More SASP-specific than CRP. Target: <2.5 pg/mL. Reductions of 20–40% post-senolytic cycle confirm SASP reduction.
• GDF15 (Growth Differentiation Factor 15): A validated SASP and aging biomarker that rises dramatically with age. Available through specialty labs (Cleveland HeartLab) and increasingly through primary care. Baseline + 6-month monitoring tracks long-term senolytic effectiveness.
• Ferritin: Routinely available. Elevated ferritin (>150 ng/mL men, >100 ng/mL women) reflects iron-driven cellular stress and chronic inflammation — both senescence-promoting. Target: 50–100 ng/mL.
• CBC (Complete Blood Count): Included in standard labs. Relevant for dasatinib users (platelet monitoring). For natural senolytics, CBC ensures no pre-existing cytopenias that might contraindicate use.
• Epigenetic age test (optional): TruDiagnostic, Elysium Index, or Thorne Biological Age — measure DNA methylation patterns to estimate biological age. Measure at baseline and at 12 months to assess biological age trajectory.

Recommended Products

Frequently Asked Questions

How often should I get blood tests for senolytic monitoring?

Baseline before starting + 4 weeks after first cycle (to confirm activity) + every 6 months ongoing. This minimal testing schedule efficiently tracks trends without excessive cost.

My hsCRP is already low (<1 mg/L). Will I see improvements?

Low baseline hsCRP suggests low senescent burden or non-SASP-driven inflammation. You may see smaller relative changes in hsCRP. Other biomarkers (GDF15, functional assessments) may show more meaningful trends.

Scientific References

• Xu M et al. Senolytics improve physical function and increase lifespan in old age. Nature Medicine. 2018. PMID: 29988130